Norgesic Forte

Vascular Headaches, Indigestion, Toothache + 20 more

Treatment

12 FDA approvals

20 Active Studies for Norgesic Forte

What is Norgesic Forte

Caffeine

The Generic name of this drug

Treatment Summary

Caffeine is a drug used for several medical conditions, including respiratory problems in premature babies, pain relief, and to reduce drowsiness. It is found naturally in coffee beans, teas, and cacao beans. Caffeine can also be included in some cosmetic products and taken orally, by inhalation, or by injection. In 1999, the FDA approved caffeine citrate injection for apnea of the premature newborn. Caffeine helps to prevent and treat apnea and bronchopulmonary dysplasia in premature babies, improving their quality of life.

Cafergot

is the brand name

image of different drug pills on a surface

Norgesic Forte Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cafergot

Caffeine

1953

390

Approved as Treatment by the FDA

Caffeine, also called Cafergot, is approved by the FDA for 12 uses including Drug Overdose and Tension Headache .

Drug Overdose

Tension Headache

Used to treat Tension Headache in combination with Acetylsalicylic acid

central nervous system depression

Respiratory Insufficiency

Chronic Fatigue Syndrome

Vascular Headaches

Used to treat Vascular Headaches in combination with Ergotamine

Fatigue

Pain

Used to treat Pain in combination with Acetaminophen

Mental Depression

Pain

Used to treat moderate Pain in combination with Acetaminophen

Chronic Pain

Used to treat Pain in combination with Acetaminophen

Tension-Type Headache

Used to treat Tension Headache in combination with Acetylsalicylic acid

Effectiveness

How Norgesic Forte Affects Patients

Caffeine is a stimulant that can make you more alert, but can also make you feel jittery and agitated. It can also make muscles relax, increase heart rate, and improve athletic performance. Caffeine can increase stomach acid and make the digestive system move faster. It is often combined with painkillers and headache medications to help relieve migraines and other types of headaches. Lastly, caffeine can make you need to pee more often.

How Norgesic Forte works in the body

Caffeine affects many parts of the body. It works by blocking adenosine receptors, which can cause alertness and reduce drowsiness. In the lungs, it raises the threshold for hypercapnia and increases oxygen consumption. Caffeine also has diuretic effects due to its stimulatory effects on kidney blood flow, and it can raise systolic blood pressure by 5 to 10 mmHg. In the heart, it can cause vasodilation and stimulate the release of catecholamines, which can lead to vasoconstriction. Finally, it can be useful in treating migraines and other types of

When to interrupt dosage

The allotment of Norgesic Forte is contingent upon the diagnosed circumstance, including Overdose, Drug, Catarrh and Athletic Performance. The quantum of dosage shifts according to the mode of delivery (e.g. Tablet or Tablet - Oral) shown in the table beneath.

Condition

Dosage

Administration

Eye

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Catarrh

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Pain relief

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Tension-Type Headache

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Acute Pain

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Toothache

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Pain

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Pain management

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Athletic Performance

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Vascular Headaches

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Indigestion

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Chronic Fatigue Syndrome

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Muscle Pain

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Bronchopulmonary Dysplasia

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Chronic Pain

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Migraine

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Sleepiness

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Fever

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Influenza

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Antacid therapy

65.0 mg, , 40.0 mg, 100.0 mg, 60.0 mg, 35.5 mg, 32.5 mg, 32.0 mg, 20.0 mg/mL, 125.0 mg/mL, 32.4 mg, 200.0 mg, 20.0 mg, 4.0 mg/mL, 30.0 mg, 50.0 mg, 1.0 mg, 0.005 mg/mL, 0.0125 mg/mL, 6.5 mg/mL, 4.0 mg, 2.0 mg, 6.0 mg, 0.002 mg/mg, 15.0 mg, 16.2 mg, 175.0 mg, 16.0 mg, 33.0 mg, 2.0 mg/mg, 0.27 mg/mg, 150.0 mg, 33.3 mg, 16.3 mg, 38.0 mg, 75.0 mg, 60.0 mg/mL, 3.0 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 25.0 mg/mL, 0.008 mg/mg, 6.3 mg/mL, 10.0 mg/mL

, Tablet, film coated - Oral, Tablet, film coated, Oral, Tablet, coated, Tablet, coated - Oral, Capsule, gelatin coated - Oral, Capsule, gelatin coated, Capsule - Oral, Tablet - Oral, Tablet, Capsule, Capsule, liquid filled, Capsule, liquid filled - Oral, Intravenous, Injection, solution, Injection, solution - Intravenous, Injection, solution - Intramuscular; Intravenous, Intramuscular; Intravenous, Injection, Injection - Intravenous, Suppository, Suppository - Rectal, Rectal, Tablet, multilayer, Tablet, multilayer - Oral, Solution, Solution - Intravenous, Solution - Oral, Syrup - Oral, Powder, Powder - Oral, Cream, Topical, Cream - Topical, Liquid - Oral, Liquid, Capsule, coated - Oral, Capsule, coated, Granule, Granule - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Syrup, Wafer - Oral, Wafer, Intravenous; Oral, Injection, solution; Solution - Intravenous; Oral, Injection, solution; Solution, Kit, Lozenge, Lozenge - Oral, Tablet, delayed release, Tablet, delayed release - Oral, Tablet, film coated - Topical, Solution - Intravenous; Oral, Kit - Ophthalmic; Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Respiratory (inhalation); Topical, Tablet, extended release, Tablet, extended release - Oral, Tablet, orally disintegrating - Oral, Tablet, orally disintegrating, Powder - Topical, Kit - Oral, Granule, for solution, Granule, for solution - Oral, Kit - Oral; Respiratory (inhalation); Topical, Kit - Ophthalmic; Oral; Topical, Oral; Respiratory (inhalation); Topical, Ophthalmic; Oral; Topical

Warnings

Norgesic Forte has one contraindication. Therefore, it must not be taken when dealing with any of the conditions outlined in the table below.

Norgesic Forte Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Caffeine may interact with Pulse Frequency

There are 20 known major drug interactions with Norgesic Forte.

Common Norgesic Forte Drug Interactions

Drug Name

Risk Level

Description

Acenocoumarol

Major

The metabolism of Acenocoumarol can be decreased when combined with Caffeine.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Caffeine.

Anagrelide

Major

The metabolism of Anagrelide can be decreased when combined with Caffeine.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Caffeine.

Bendamustine

Major

The metabolism of Bendamustine can be decreased when combined with Caffeine.

Norgesic Forte Toxicity & Overdose Risk

The most toxic dose of caffeine in rats is 192mg/kg. In humans, a fatal overdose of caffeine is about 10-14 grams, or roughly 150-200mg/kg of body weight. An overdose of caffeine can cause symptoms such as seizures, nausea, vomiting, diarrhea, agitation, anxiety, restlessness, insomnia, and rapid heartbeat. In severe cases, intubation may be needed to protect the airway. Treatment includes administering activated charcoal and hemodialysis to prevent further complications, benzodiazepines to prevent or treat seizures, IV fluids and vasopressors to treat hypotension, magnesium and beta blockers

image of a doctor in a lab doing drug, clinical research

Norgesic Forte Novel Uses: Which Conditions Have a Clinical Trial Featuring Norgesic Forte?

Currently, 429 active studies are examining the potential of Norgesic Forte in alleviating symptoms of Chronic Fatigue Syndrome, Chronic Pain and Migraine.

Condition

Clinical Trials

Trial Phases

Influenza

29 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 1, Phase 3

Pain relief

15 Actively Recruiting

Early Phase 1, Not Applicable, Phase 4, Phase 2, Phase 1

Chronic Pain

130 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1

Chronic Fatigue Syndrome

43 Actively Recruiting

Not Applicable, Phase 2, Phase 3, Phase 1, Phase 4

Indigestion

6 Actively Recruiting

Phase 3, Not Applicable, Phase 2

Respiratory Insufficiency

0 Actively Recruiting

Migraine

13 Actively Recruiting

Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4

Premature Birth

4 Actively Recruiting

Phase 3, Not Applicable, Phase 2

Catarrh

0 Actively Recruiting

Vascular Headaches

0 Actively Recruiting

Tension-Type Headache

0 Actively Recruiting

Athletic Performance

1 Actively Recruiting

Not Applicable

Eye

1 Actively Recruiting

Not Applicable

Toothache

0 Actively Recruiting

Muscle Pain

3 Actively Recruiting

Phase 4, Not Applicable, Phase 2

Sleepiness

4 Actively Recruiting

Not Applicable, Phase 3

Pain

0 Actively Recruiting

Fever

2 Actively Recruiting

Not Applicable, Phase 4

Mental Depression

0 Actively Recruiting

Pain management

0 Actively Recruiting

Norgesic Forte Reviews: What are patients saying about Norgesic Forte?

5

Patient Review

3/16/2012

Norgesic Forte for Muscle Spasm

I've been using this drug for 25 years to manage my muscle pain and spasms, and it's the only thing that's worked for me. Now I can't get a refill because the pharmacy says it's no longer available. If anyone knows where I can find it, please let me know.

5

Patient Review

6/22/2016

Norgesic Forte for Muscle Spasm

I've been using this treatment for nearly half a century, and it works well for me.

5

Patient Review

9/23/2009

Norgesic Forte for Muscle Spasm

I've been dealing with back problems for over 25 years and this medication finally offers me some relief. I alternate between taking this and ibuprofen as directed by my doctor, which seems to intensify the effects of both medications.

5

Patient Review

8/17/2009

Norgesic Forte for Muscle Spasm

This medication quickly helped me get back to work by reducing the muscle spasms I was experiencing.

5

Patient Review

2/5/2009

Norgesic Forte for Muscle Spasm

5

Patient Review

6/10/2009

Norgesic Forte for Muscle Spasm

The only issue I have is that the caffeine in it makes it hard for me to fall asleep. Otherwise, it has been helpful.

5

Patient Review

1/5/2014

Norgesic Forte for Muscle Spasm

Make sure to drink lots of water and take this treatment with food. Within three days, my back pain was gone.

4.7

Patient Review

4/6/2011

Norgesic Forte for Muscle Spasm

This medication helped to get rid of my migraines very quickly; however, it left me feeling so tired that I was unable to focus at work.

4.7

Patient Review

5/19/2011

Norgesic Forte for Muscle Spasm

I've been taking this medication for a while now, and suddenly I'm unable to get it. I'm not sure why that is and would appreciate more information.

4.3

Patient Review

7/30/2012

Norgesic Forte for Muscle Spasm

I was taking this medication when I suddenly started to slur my words. Within two days, I couldn't speak at all. It's unbelievable that a medication could have that effect on someone.

4

Patient Review

6/24/2013

Norgesic Forte for Muscle Spasm

I fractured my back when I was younger, and ever since then I occasionally get swelling, pain, and spasms in my back that aren't alleviated by narcotics. This drug has been a lifesaver.

3

Patient Review

1/3/2009

Norgesic Forte for Muscle Spasm

2.3

Patient Review

7/20/2012

Norgesic Forte for Muscle Spasm

Norgesic Forte always worked well for me in the past, providing relief very quickly. I've recently had some neck muscle spasms and was prescribed a different medication by my doctor that took over a week to work. If Norgesic Forte is no longer on the market, I really hope they bring it back--nothing else works as well!

Patient Q&A Section about norgesic forte

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

When should I take Norgesic Forte?

"1-2 Norgesic tablets should be taken three times daily, or as prescribed by a physician. For Norgesic Forte, 1 tablet should be taken three times daily. In more severe cases, the dosage can be increased to 2 tablets three times daily, if prescribed by a physician. This medication is not recommended for children under the age of twelve."

Answered by AI

What is Norgesic Forte used for?

"Aspirin reduces pain and inflammation. Caffeine increases the effects of orphenadrine.

This medication is a combination of orphenadrine, aspirin, and caffeine. It acts to relieve muscle pain. Typically, it is used in addition to rest, physical therapy, and other treatments. Orphenadrine works to relieve muscle pain. Aspirin reduces pain and inflammation. Caffeine magnifies the effects of orphenadrine."

Answered by AI

Is Norgesic a painkiller?

"Norgesic is a medication that combines a muscle relaxant, a pain reliever, and caffeine. It is typically used to treat injuries and other painful muscular conditions."

Answered by AI

Is Norgesic Forte still available?

"The brand name Norgesic Forte has been discontinued in the United States. There may be generic equivalents available if the generic versions of this product have been approved by the FDA."

Answered by AI

Clinical Trials for Norgesic Forte

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Have you considered Norgesic Forte clinical trials?

We made a collection of clinical trials featuring Norgesic Forte, we think they might fit your search criteria.
Go to Trials
Image of Arizona State University in Phoenix, United States.

App-based Breathing Program for Migraine

18+
All Sexes
Phoenix, AZ

Migraine is one of the most common neurological disorders, characterized by recurrent headaches, sensitivity to light and movement, nausea, and autonomic dysregulation. Although mind-body interventions like biofeedback have shown their efficacy, they remain underutilized due to barriers such as transportation, time constraints, lack of awareness, stigma, and cost. A targeted approach to enhancing HRV is HRV biofeedback (HRVB), a technique using visual or auditory feedback to help people regulate HRV through slow-paced breathing and positive emotional regulation to promote ANS balance and emotional resilience. Investigators will conduct a remotely delivered pilot RCT of an 8-week, 10 min/day, novel app-based HRVB intervention compared to a sham control intervention (matching intervention time and attention with no biofeedback component) in adult with chronic migraine. Investigators hypothesize data collected from the study will: a) support the feasibility and acceptability of the remotely delivered app-based HRVB intervention among adults with chronic migraine, and b) provide insights into refining the intervention by examining patterns of change in migraine and psychological outcomes from pre- to post-intervention.

Waitlist Available
Online Trial

Arizona State University

Have you considered Norgesic Forte clinical trials?

We made a collection of clinical trials featuring Norgesic Forte, we think they might fit your search criteria.
Go to Trials
Image of BTT Medical Institute Aventura North in Miami, United States.

Niagen®Plus for Fatigue

18+
All Sexes
Miami, FL

The goal of this study is to learn about the safety of Niagen®Plus, an injectable form of nicotinamide riboside (NR), and to see how it affects levels of NAD+ in the blood. Niagen®Plus will be given either by subcutaneous (under the skin) or intramuscular (into the muscle) injection at two dose levels (50 mg or 100 mg). The main questions this study aims to answer are: Is Niagen®Plus safe and well-tolerated when given by injection several times over 100 days? How do NAD+ levels in blood change after repeated doses of Niagen®Plus? What are participants' and clinicians' experiences with the injections? Researchers will also look at changes in fatigue, sleep, quality of life, inflammation markers, mitochondrial efficiency, and perceived skin appearance. Participants will: Receive three injections in clinic on Days 1-3, followed by a Day 10 follow-up visit Self-inject Niagen®Plus at home three times per week from Days 10-100 Return to the clinic on Days 40 and 100 for safety and laboratory testing Complete short surveys about fatigue, sleep, and overall well-being throughout the study The study will include 40 generally healthy adults and will last about 100 days per participant.

Phase 1
Recruiting

BTT Medical Institute Aventura North

ChromaDex, Inc.

Have you considered Norgesic Forte clinical trials?

We made a collection of clinical trials featuring Norgesic Forte, we think they might fit your search criteria.
Go to Trials